Eight Sleep Fixes, Ranked: What the Research Says About the Products Filling Your Cart
Photo: Bernard van Risenburgh, CC0, via Wikimedia Commons
Roughly one in three American adults reports not getting enough sleep, and the market has noticed. Sleep aids — supplements, gadgets, wearables, and accessories — now constitute a multibillion-dollar domestic industry, with melatonin gummies alone flying off pharmacy shelves in quantities that would have seemed implausible a decade ago.
Popularity, however, is not evidence. Below, eight of the most heavily marketed sleep interventions are ranked against what peer-reviewed research actually supports. The verdicts fall into three tiers: evidence-backed, partially supported, and expensive placebo.
The Rankings
1. Consistent sleep and wake times — Evidence-backed. Circadian science is unambiguous: a stable schedule strengthens the body's internal clock more reliably than almost any product sold. It costs nothing and outperforms nearly everything on this list.
2. Cognitive behavioral therapy for insomnia (CBT-I) — Evidence-backed. CBT-I is the first-line, guideline-recommended treatment for chronic insomnia, with effect sizes that match or exceed sleeping medications over the long term. Digital versions have growing supporting evidence. It remains underused relative to its track record.
3. Weighted blankets — Partially supported. A handful of small trials suggest modest benefits for subjective sleep quality and anxiety, particularly in some populations with psychiatric conditions. The research base is thin but not empty. A reasonable, low-risk purchase for those who find them comfortable.
4. Magnesium — Partially supported. Evidence for magnesium improving sleep is limited mostly to people with actual deficiency, which is uncommon in those eating a varied diet. Mega-dose 'sleep mocktails' built on the trend carry a real downside: gastrointestinal distress, and in excess, more serious risks for certain individuals.
5. Blue light blocking glasses — Partially supported, weakly. Laboratory studies show that blocking short-wavelength light in the evening can reduce melatonin suppression, but real-world trials on sleep outcomes are mixed and generally modest. Dimming screens and lights before bed achieves much the same effect at no cost.
6. Melatonin gummies — Partially supported with caveats. Melatonin has legitimate uses, chiefly for circadian rhythm problems like jet lag and shift work. As a general sleep aid, effects are small. More concerning: independent analyses have repeatedly found that gummy doses frequently exceed label claims, sometimes dramatically, and no FDA oversight governs the supplement category.
7. Mouth tape — Expensive placebo (with safety caveats). There is no meaningful evidence that taping the mouth at night improves sleep quality in the general population, and it can be hazardous for people with nasal obstruction, sleep apnea, or reflux, for whom breathing through the mouth is a compensatory mechanism. An obstructed airway should be evaluated, not taped shut.
8. 'Sleep cocktails' of stacked supplements — Expensive placebo. Combining magnesium, glycine, L-theanine, ashwagandha, and melatonin into one powder does not convert weak individual evidence into strong combined evidence, and stacking increases the odds of interactions and side effects.
Why the Market Outpaces the Science
The pattern across this list is instructive. The interventions with the strongest evidence — behavioral consistency and CBT-I — are the least profitable, while the weakest evidence clusters around the most heavily advertised products. Supplements occupy a regulatory gray zone under the Dietary Supplement Health and Education Act, meaning manufacturers can market them without demonstrating efficacy before sale. Devices and accessories face even lighter scrutiny.
A Reasonable Hierarchy
For the sleepless American consumer, a sensible order of operations emerges from the data. First, stabilize the schedule and the bedroom environment — dark, cool, quiet. Second, if insomnia persists beyond a few weeks, seek CBT-I rather than a checkout cart. Third, if a product still appeals, prefer the ones with at least partial evidence and a low risk profile, and treat melatonin as a precision tool for jet lag rather than a nightly dessert.
The billion-dollar industry would prefer that step one come last. The research says it should come first.
